Gilberto Lopes (Sylvester Comprehensive Cancer Center at the University of Miami, Florida, USA), a steering committee member of CCC19, tells us about the registry collating data on cancer patients with comorbid COVID-19 to provide an evidence base for future decision-making. <a href="https://bit.ly/Lopes-COVID-19-podcast" target="_blank" rel="noopener">Find more on Medicine Matters oncology</a> Image credit: © koto_feja/Getty Images/iStock

Gilberto Lopes (Sylvester Comprehensive Cancer Center at the University of Miami, Florida, USA), a steering committee member of CCC19, tells us about the registry collating data on cancer patients with comorbid COVID-19 to provide an evidence base for future decision-making. Find more on Medicine Matters oncology Image credit: © koto_feja/Getty Images/iStock

Gilberto Lopes (Sylvester Comprehensive Cancer Center at the University of Miami, Florida, USA), a steering committee member of CCC19, tells us about the registry collating data on cancer patients with comorbid COVID-19 to provide an evidence base for future decision-making. <a href="https://bit.ly/Lopes-COVID-19-podcast" rel="noopener noreferrer">Find more on Medicine Matters oncology</a> Image credit: © koto_feja/Getty Images/iStock

Share CCC19: Introducing The COVID-19 and Cancer Consortium (with Gilberto Lopes)

Sign up to save your podcasts

CCC19: Introducing The COVID-19 and Cancer Consortium (with Gilberto Lopes)

CCC19: Introducing The COVID-19 and Cancer Consortium (with Gilberto Lopes)